Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Tries To Rebuild Its Science Reputation, Plans New Projects

This article was originally published in The Gray Sheet

Executive Summary

FDA is embarking on a series of projects this year to address key scientific questions and, in the process, help rebuild the agency's suffering reputation

You may also be interested in...



Regulatory News In Brief

Pediatric device report: FDA submits its first annual 1report to Congress on pre-market approval statistics for pediatric-use devices, posted April 28. The 2007 FDA Amendments Act requires the agency to submit the reports as part of a government effort to encourage development of devices for young patients. During fiscal 2008, FDA approved 15 PMAs and panel-track supplements and two humanitarian-use devices that treat or diagnose conditions with pediatric subpopulations, including Abbott's Freestyle Navigator continuous glucose monitor and Thoratec's Heartmate II left ventricular assist system. Two devices were specifically labeled for use in pediatric patients in FY 2008

Regulatory News In Brief

Pediatric device report: FDA submits its first annual 1report to Congress on pre-market approval statistics for pediatric-use devices, posted April 28. The 2007 FDA Amendments Act requires the agency to submit the reports as part of a government effort to encourage development of devices for young patients. During fiscal 2008, FDA approved 15 PMAs and panel-track supplements and two humanitarian-use devices that treat or diagnose conditions with pediatric subpopulations, including Abbott's Freestyle Navigator continuous glucose monitor and Thoratec's Heartmate II left ventricular assist system. Two devices were specifically labeled for use in pediatric patients in FY 2008

People In Brief

Peer Portner: The pioneer of the first electrical left ventricular assist device died Feb. 9, from cancer. Peer Portner, a Ph.D. trained in nuclear physics, lead a multidisciplinary team at Stanford University in the 1970s to develop the Novacor LVAD, used in the first bridge-to-transplant procedure in 1984. Portner also founded Novacor Medical, which was acquired by Baxter Healthcare in 1988. WorldHeart acquired the Novacor technology in 2000 and continues to market, on a limited basis, an updated version of the product as a bridge-to-transplant pump, and, in Europe, as a longer-term destination therapy

Related Content

Topics

UsernamePublicRestriction

Register

MT027157

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel